Simulations to Evaluate HIV Vaccine Trial Designs

Simulation

Volumn 71, Issue 4, 1998, Pages 228-241

  Adams, Andrew L ^a   Barth Jones, Daniel C ^a   Koopman, James S ^a   Chick, Stephen E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

epidem ics; HIV; HIVSIM; mathematical models; Retrospective Partner Trial; statis tical methods; transmission; vaccine

Indexed keywords

EID: 0001393030     PISSN: 00375497     EISSN: None     Source Type: Journal    
DOI: 10.1177/003754979807100403     Document Type: Article

References (53)

1. Koopman, J.S., Simon, C.P., and Jacquez, J.A. “Assessing Contagiousness Effects of Vaccines and Risk Factors for Transmission.” Modeling the AIDS Epidemic: Planning, Policy and Prediction, E. H. Kaplan and M. I. Brandeau, editors, Raven Press, New York, pp 439-460, 1994.
2. Koopman, J.S., Little, R.J. “Assessing HIV Vaccine Effects.” American Journal of Epidemiology, Vol. 142, No.10, pp 1113-1120, 1995.
3. Rida, W.N. “Assessing the Effect of HIV Vaccination on Infectiousness.” Statistics in Medicine, Vol.15, No. 21-22, pp 2393-2404, 1996.
4. Halloran, M.E. “Discussion: Assessing the Effect of HIV Vaccination on Infectiousness.” Statistics in Medicine, Vol. 15, No. 21-22, pp 2405-2412, 1996.
5. Longini, I.M. Jr., Datta, S., Halloran, M.E. “Measuring Vaccine Efficacy for Both Susceptibility to Infection and Reduction in Infectiousness for Prophylactic HIV-1 Vaccines.” Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, Vol. 13, No. 5, pp 440-447, 1996.
6. Halloran, M.E., Longini, I.M. Jr., Struchiner, C.J. “Study Designs for Evaluating Different Efficacy and Effectiveness Aspects of Vaccines.” American Journal of Epidemiology, Vol. 146, No. 10, Nov. 15, pp 789-803, 1997.
7. Rida, W., Fast, P., Hoff, R., Fleming, T. “Intermediate-Size Trials for the Evaluation of HIV Vaccine Candidates: A Workshop Summary.” Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, Vol. 16, No. 3, pp 195-203, 1997.
8. Datta, S., Halloran, M.E., and Longini, I.M. Jr. “Augmented HIV Vaccine Trial Design for Estimating Reduction in Infectiousness and Protective Efficacy.”Statistics in Medicine, Vol. 17, pp 185-200, 1998.
9. Longini, I.M. Jr., Sagatelian, K., Rida, W.N., Halloran, M.E. “Optimal Vaccine Trial Design when Estimating Vaccine Efficacy for Susceptibility and Infectiousness from Multiple Populations.” Statistics in Medicine, Vol. 17, pp 1121-1136, 1998.
10. Longini, I., Kitayaporn, D., Vanichseni, S., Choopanya, K., Hudgens, M., Halloran, M., Mastro, T., Mock, P. “Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines from Field Trials in Developing Countries.” International Conference on AIDS, Vol. 12, No. 1, pp 955 (abstract no. 435552), 1998.
11. Smith, P.G., Rodrigues, L.C., Fine, P.E. “Assessment of the Protective Efficacy of Vaccines Against Common Diseases Using Case-Control and Cohort Studies.” International Journal of Epidemiology, Vol. 13, No. 1, pp 87-93, 1984.
12. Halloran, M.E., Struchiner, C.J., Longini, I.M. Jr. “Study Designs for Evaluating Different Efficacy and Effectiveness Aspects of Vaccines.” American Journal of Epidemiology, Vol. 146, No. 10, pp 789-803, 1997.
13. Rhodes, P.H., Halloran, M.E., and Longini, I. M. Jr. “Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility.” Journal of Research Statistics, Soc. B. Vol. 58, No. 4, pp 751-762, 1996.
14. Chen, R.T., Orenstein, W.A. “Epidemiologic Methods in Immunization Programs.” Epidemiologic Reviews, Vol. 18, No. 2, pp 99-117, 1996.
15. Orenstein, W.A., Bernier, R.H., Hinman, A.R. “Assessing Vaccine Efficacy in the Field. Further Observations. “ Epidemiologic Reviews, Vol. 10, pp 212-41, 1988.
16. Orenstein, W.A., Bernier, R.H., Dondero, T.J., Hinman, A.R., Marks, J.S., Bart, K.J., Sirotkin, B. “Field Evaluation of Vaccine Efficacy.” Bulletin of the World Health Organization, Vol. 63, No. 6, pp 1055-68, 1985.
17. Basch, P.F. Vaccines and World Health: Science, Policy, and Practice, Oxford University Press, New York, 1994.
18. Longini, I.M., Hudgins, M., Halloran, M.E., Sagatelian, K. “A Markov Model for Measuring Vaccine Efficacy for Both Susceptibility to Infection and Reduction in Infectiousness for Prophylactic HIV Vaccines.” Statistics in Medicine, in press, 1998.
19. Datta, S., Halloran, M.E., Longini, I. M. Jr. “Augmented HIV Vaccine Trial Design for Estimating Reduction in Infectiousness and Protective Efficacy.” Statistics in Medicine, Vol. 17, No. 2, pp 185-200, 1998.
20. Longini, I. M. Jr., Datta, S., Halloran, M.E. “Measuring Vaccine Efficacy for Both Susceptibility to Infection and Reduction in Infectiousness for Prophylactic HIV-1 Vaccines.” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 13, No. 5, pp 440-7, 1996.
21. Jacquez, J.A. Compartmental Analysis in Biology and Medicine, Third Edition, BioMedware, Ann Arbor, Michigan, 1996.
22. Rhodes, P.H., Halloran, M.E., and Longini, I. M. Jr. “Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility.” Journal of Research Statististics Soc. B, Vol. 58, No. 4, pp 751-762, 1996.
23. Anderson, R.M., May, R. Infectious Diseases in Humans: Dynamics and Control, Oxford University Press, Oxford, 1991.
24. Blower, S.M. and McLean, A.R. “Prophylactic Vaccines, Risk Behavior Change and the Probability of Eradicating HIV in San Francisco.” Science, Vol. 265, pp 1451-1454, 1994.
25. Leitner, T., Escanilla, D., Franzen, C., Uhlen, M., Albert, J. “Accurate Reconstruction of a Known HIV-1 Transmission History by Phylogenetic Tree Analysis. “ Proceedings of the National Academy of Science USA, Vol. 93, No. 20, pp 10864-10869, 1996.
26. Arnold, C., Balfe, P., Clewley, J.P. “Sequence Distances Between ENV Genes of HIV-1 from Individuals Infected from the Same Source: Implications for the Investigation of Possible Transmission Events.” Virology, Vol. 211, No. 1, pp 198-203, 1995.
27. Crandall, K.A. “Intraspecific Phylogenetics: Support for Dental Transmission of Human Immunodeficiency Virus.” Journal of Virology, Vol. 69, No. 4, pp 2351-2356, 1995.
28. Delwart, E., Busch, M., Kalish, M., Mosley, J., and Mullins, J. “Rapid Molecular Epidemiology of Human Immunology Virus Transmission.” AIDS Research and Human Retroviruses, Vol. 11, No. 9, pp 1081-1093, 1995.
29. Halloran, M.E. Concepts of Infectious Disease Epidemiology in Modern Epidemiology, Second Ed., K. J. Rothman and S. Greenland, editors, Lippincott-Raven, Philadelphia, 1998.
30. Barth-Jones, D.C., Adams, A., Lange, K., Chick, S., Koopman, J.S. “Retrospective Partner Trials HIV Vaccine Study Design for Measurement of Vaccine Effect.” Proceedings of the 12th World AIDS Conference, Prevention and Epidemiology, Geneva, Switzerland, Monduzzi Editore: Bologna, Italy, Vol. 3, pp 285-289, 1998.
31. Barth-Jones, D., Adams, A., Lange, K., Koopman, J. “Retrospective Partner Trials HIV Vaccine Study Design for Measurement of Vaccine Effects.” International Conference on AIDS, Vol. 12, No. 1. pp 954 (abstract no. 43549), 1998.
32. Dietz, K. “On the Transmission Dynamics of HIV.” Math. Biosci., Vol. 90, pp 397-414, 1988.
33. Dietz, K. and Hadeler, K.P. “Epidemiological Models for Sexually Transmitted Diseases.” Journal of Math. Biol., Vol. 26, No. 1, pp 1-25, 1988.
34. Morris, M. “Sexual Networks and HIV.” AIDS, Vol. 11, (Suppl A), pp S209-S216, 1997.
35. Mastro, T.D. and De Vincenzi, I. “Probabilities of Sexual HIV-1 Transmission.” AIDS, Vol. 10 (Suppl A), No. S75-S82, 1996.
36. Leynaert, B., Downs, A.M., De Vincenzi, I. “Heterosexual Transmission of Human Immunodeficiency Virus: Variability of Infectivity Throughout the Course of Infection. European Study Group on Heterosexual Transmission of HIV.” American Journal of Epidemiology, Vol. 148, No. 1, pp 88-96, 1998.
37. Longini, I.M. Jr., Clark, W.S., Haber, M., and Horsburgh, R. Jr. “The Stage of HIV Infection: Waiting Times and Infection Transmission Probabilities.” Mathematical and Statistical Approaches to AIDS Epidemiology, C. Castillo-Chavez, editor, Springer-Verlag, Berlin, New York, Vol. 83, pp 111-137. Lecture Notes in Biomathematics, 1989.
38. Jacquez, J.A., Koopman, J.S., Simon, C.P., and Longini, I.M. Jr. “Role of Primary Infection in Epidemic of HIV Infection in Gay Cohorts.” Journal of Acquired Immune Deficiency Syndrome, Vol. 7, No. 11, pp 1169-1184, 1994.
39. Koopman, J.S., Simon, C.P., Jacquez, J.A., and Park, T.S. “Selective Contact within Structured Mixing with an Application to HIV Transmission Risk from Oral and Anal Sex.” Mathematical and Statistical Approaches to AIDS Epidemiology, C. Castillo-Chavez, editor, Springer-Verlag, Berlin, New York, 83, pp 316-348. Lecture Notes in Biomathematics, 1989.
40. Ross, M.W., Rosser, B.R. “Dimensions of Sexual Behaviour in Homosexual Men: Replicability Across Time and Country.” Psychol. Rep., Vol. 68, No. 2, pp 607-612, 1991.
41. Coxon, A.P.M., Coxon, N.H., Weatherburn, P., et al. “Sex Role Separation in Sexual Diaries of Homosexual Men.” AIDS, Vol. 7, pp 877-882, 1993.
42. Van Druten, H., Van Griensven, F. and Hendricks, J. “Homosexual Role Separation: Implications for Analyzing and Modeling the Spread of HIV.” Journal of Sexual Research, Vol. 29, pp 477-499, 1992.
43. Morris, M., Kretzschmar, M. “Concurrent Partnerships and the Spread of HIV.” AIDS, Vol. 11, No. 5, pp 641-648, 1997.
44. Morris, M. and Kretzschmar, M. “Concurrent Partnerships and Transmission Dynamics in Networks.” Social Networks, Vol. 17, pp 299-318, 1995.
45. Anderson, R.M. “The Epidemiology of HIV Infection: Variable Incubation Plus Infection Periods and Heterogeneity in Sexual Activity.” J. R. Stat. Soc. A., Vol. 151, pp 66-93, 1988.
46. Anderson, R.M., Gupta, S., and Ng, W. “The Significance of Sexual Partner Contact Networks for the Transmission Dynamics of HIV.” Journal of Acquired Immune Deficit Syndrome, Vol. 3, pp 417-429, 1990.
47. Morris, M., Zavisca, J., Dean, L. “Social and Sexual Networks: Their Role in the Spread of HIV/AIDS Among Young Gay Men.” AIDS Educ. Prev., Vol. 7, No. 5 (Suppl.), pp 24-35, 1995.
48. Morris, M. “Sexual Networks and HIV.” AIDS, Vol. 11 (Suppl A), pp 209-216, 1997.
49. Jacquez, J., Simon, C., and Koopman, J. “Structured Mixing: Heterogeneous Mixing by the Definition of Activity Groups.” Mathematical and Statistical Approaches to AIDS Epidemiology, C. Castillo-Chavez, ed. Springer-Verlag, Berlin, New York, Vol. 83, pp 301-315, Lecture Notes in Biomath., 1989.
50. Koopman, J., Simon, C., Jacquez, J., Joseph, J., Sattenspiel, L., Park, T. “Sexual Partner Selectiveness Effects on Homosexual HIV Transmission Dynamics.” Journal of Acquired Immune Deficiency Syndrome, Vol. 1, No. 5, pp 486-504, 1988.
51. Halloran, M.E., Longini, I.M. Jr., Struchiner, C.J. “Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing Models.” American Journal of Epidemiology, Vol. 144, No. 1, pp 83-97, 1996.
52. Longini, I.M. Jr. and Halloran, M.E. “A Frailty Mixture Model for Estimating Vaccine Efficacy.” Applied Statistics, Vol. 45, No. 2, pp 165-173, 1996.
53. Sas. SAS/Stat User's Guide, Ver. 6. Cary, NC, SAS Institute, 1992.